Group 1 - The core point of the article is that Universal Medical (02666.HK) has received approval from the China Securities Regulatory Commission to issue a public corporate bond in China with a total principal amount of up to RMB 8 billion [1] - The remaining balance of the corporate bond is RMB 5.4 billion, and the bond will be issued in tranches, with the fourth tranche not exceeding RMB 1 billion [1] - The stock price of Universal Medical closed at HKD 6.28, with a 0.32% increase, and the trading volume was 2.293 million shares, amounting to HKD 14.314 million [1] Group 2 - Universal Medical has a market capitalization of HKD 12.609 billion, ranking 5th in the healthcare services sector [2] - Key financial metrics include a Return on Equity (ROE) of 12.39%, revenue of RMB 14.701 billion, and a net profit margin of 17.61% [2] - The company has a debt ratio of 73.38%, which is slightly lower than the industry average of 74.15% [2]
环球医疗(02666.HK)附属拟发行本金总额不超过10亿元公司债